29: Drug Safety After Approval: A Conversation with FDA’s Gerald Dal Pan, MD
We Can Do This! ›18:03 | Dec 22nd, 2025
Sally Greenberg speaks with Gerald Dal Pan, M.D., Director of the FDA’s Office of Surveillance and Epidemiology, to explain how the FDA identifies drug safety signals, responds to emerging safety conc...Show More
Recommendations